The subject invention provides a use of tibolone and a SERM for the
manufacture of a medicine for the treatment of an estrogen-deficiency
related complaint and for the prevention of a recurrence of breast cancer
in females suffering from, or at risk for breast cancer that exhibit the
estrogen-deficiency related complaint.